Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K/AKT/mTOR and HIF-1/VEGF cascade

Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K/AKT/mTOR and HIF-1/VEGF cascade

Metabolic associated fatty liver disease (MAFLD) is the most common chronic liver disease that has no viable treatment. Curcumin (Cur) and resveratrol (Res) are two natural products that have been studied for their potential to ameliorate MAFLD. However, while these compounds have been investigated...

Full description

Bibliographic Details
Main Authors: Yuhui He, Huan Wang, Shiling Lin, Tao Chen, Dennis Chang, Yibin Sun, Chenxiang Wang, Yang Liu, Yusheng Lu, Jianyuan Song, Shaohua Li, Wen Xu, Yanxiang Lin, Yanfang Zheng, Xian Zhou, Qiumei Huang, Mingqing Huang
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Curcumin
Resveratrol
Metabolism-related fatty liver disease
Hepatic steatosis
Synergy
PI3K/AKT/mTOR
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223010703

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223010703

Similar Items